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Highlights 
• Adult lung epithelial progenitor cells are capable of generating self-organizing 
structure in 3D culture. 
• Lung organoids have the capacity for clonal propagation and multi-lineage 
differentiation.  
• Lung organoids recapitulate the regenerative process proposed from in vivo 
study. 
• Lung organoid co-culture provides a platform to study niche functions in adult 
stem cell regulation. 
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Abstract 
The remarkable regenerative capacity of the lung suggests that stem cells could be 
of therapeutic importance in diverse lung diseases; however, the successful 
exploitation of lung stem cell biology has long been hampered by our inability to 
maintain and expand adult lung stem cells while retaining their multi-lineage potential 
in vitro. Recently, advances in our understanding of stem cell niches and the role of 
key signalling modulators in controlling stem cell maintenance and differentiation 
have fuelled the development of new in vitro three-dimensional (3D) culture 
technologies that sustain the stem cell-driven formation of near-physiological, self-
organizing structures called organoids. Here we review basic approaches to 
organoid model systems and highlight recent achievements in the generation of 
organoids from adult stem and progenitor cells of both the murine and human lungs. 
We evaluate current applications in studying cellular changes in proliferation, 
differentiation, plasticity, and cell polarity, and cellular and molecular crosstalk of 
epithelial cells with stroma. Advantages and limitations of organoids for clinical use 
are also discussed.  
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1. Introduction 
The lung is a complex organ composed of numerous types of interconnected 
epithelial cells, stromal cells, including vascular cells and immune cells, and 
extracellular matrix (ECM) that synergize to maintain lung integrity. In the last 
decade there has been significant progress in understanding the organization of 
stem and progenitor cells in the adult lung. The analysis of lung injury models, 
combined with in vivo lineage-tracing techniques, has identified various potential 
epithelial stem and progenitor cells that respond to local injury and replace the 
damaged epithelial cells. These achievements have opened up a new era for the 
potential exploitation of adult stem cells in clinical applications for degenerative lung 
diseases arising from the impairment or depletion of specific cell types. However, 
historically it has been challenging to maintain and expand these stem cells and to 
direct their lineage specification to reproduce such physiological functions as airway 
patency, mucociliary clearance, and gas exchange in vitro. This is partly due to the 
limited reproduction of multi-cellular organization of the lung in vitro.  
For decades, researchers have attempted to find suitable in vitro model systems that 
can recapitulate in vivo functions and processes, from molecular and cellular levels 
to whole tissue, and organ functions. Two-dimensional (2D) model systems, such as 
monolayer cell cultures, have been used to assess the clonogenicity of adult 
progenitor cells and to induce lineage differentiation of pluripotent stem cells. 
However, the lack of structural and physical supports provided by stromal 
components including the ECM, has been a barrier to understand cellular and 
molecular functions under physiological and pathological conditions. Recent 
progresses in isolating numerous types of cells, including epithelial progenitor cells 
and stromal cells, and defining niche factors that are important for lung development 
has led to the establishment of an in vitro three-dimensional (3D) lung culture system, 
termed lung organoid cultures. In organoids, epithelial stem and progenitor cells, 
cultured in ECM supplemented with either a mixture of growth factors or stromal cells, 
self-organize into complex structures retaining clusters of multi-lineage epithelial 
cells. Lung organoids recapitulate various features of the lung including 
heterogeneous cell composition, spatial organization and retention of a stem cell 
population harboring the capacity for both self-renewal and differentiation (Fatehullah 
et al., 2016). Importantly, lung organoids provide an in vitro model system for 
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studying regenerative mechanisms of epithelial stem and progenitor cells proposed 
from in vivo studies.  
In this review, we will focus on recent advances in the murine and human organoids 
derived from adult primary lung epithelial cells. This review will provide an overview 
of the potential of adult lung stem and progenitor cell that are responsible for lung 
homeostasis, regeneration, and enable the generation of organoids retaining multi-
lineage epithelial cell types. The value of lung organoids as potent model systems for 
understanding tissue regeneration, lineage specification, and disease modeling will 
be evaluated. Future challenges for clinical application will also be discussed.   
2. Adult lung stem and progenitor cells 
The adult lung is a highly quiescent tissue with a slow turnover rate (<1% per day) of 
airway and alveolar epithelia (Bowden, 1983; Goss, 1966; Kotton and Morrisey, 
2014). However, following tissue damage, lungs demonstrate extraordinary 
regenerative capacity to repair tissue damage and restore function. Recent 
advances in cell lineage tracing, flow cytometric analyses, and cell culture 
techniques have identified the specific stem and progenitor cells responsible for 
these extraordinary feats. In this review, we will focus on stem and progenitor cells 
capable of generating lung organoids. A brief overview is provided in Table 1.  
2.1. Epithelial stem and progenitor cells of the adult mouse lung 
Within the mammalian lung, there are a large number of epithelial cells along the 
pulmonary axis, stretching from the proximal to the distal end. This axis can be sub-
divided into three regions, the tracheobronchial, bronchiolar, and alveolar region. 
Each region is lined by specialized epithelial cell types that are maintained by 
regional epithelial stem and progenitor cells with potential to generate lung organoids.  
Basal Cells. Basal cells expressing Trp63, Krt5, and Ngfr lie close to the basal 
lamina and comprise ~30% of the pseudostratified mucociliary epithelium lining the 
trachea region. Lineage tracing studies have shown the maintenance of this region 
by basal and basal luminal precursor cells with a slow turnover during steady state 
(Ghosh et al., 2011; Mori et al., 2015; Mou et al., 2016; Rock et al., 2009; Watson et 
al., 2015). Following injury, basal cells demonstrate extensive proliferative and self-
renewal capacity to differentiate into the mucous- and serous-secreting cells as well 
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as ciliated cells, secretory goblet, and club lineage cells (Borthwick et al., 2001; 
Ghosh et al., 2011; Hegab et al., 2011; Hong et al., 2004a, b; Rock et al., 2009). The 
Notch signalling pathway has been highlighted as playing a critical role in regulating 
the fate decision of basal cells between secretory lineage cells and ciliated cells 
(Carraro and Stripp, 2015; Pardo-Saganta et al., 2015; Rock et al., 2011b). Recently, 
club cells have been shown to revert into the lost basal cells post genetic ablation of 
basal cells in vivo suggesting the contribution of cellular plasticity to regenerative 
process (Pardo-Saganta et al., 2015; Tata et al., 2013). However, the molecular 
mechanisms how these differentiated cells work together with stem or progenitor 
cells to maintain lung integrity still remain to be fully elucidated.  
Club cells. Club cells expressing secretoglobin family 1a member 1 (Scgb1a1, also 
known as CC10 or CCSP) are columnar epithelial cells comprising the majority of the 
bronchiolar epithelial region. Given their capacity for both self-renewal and 
differentiation into ciliated cells over the long-term, club cells have been considered 
stem cells in the bronchiolar epithelium at steady state (Rawlins et al., 2009). 
Following the administration of naphthalene to selectively ablate club cells, 
naphthalene-resistant variant club cells near to neuroendocrine bodies (NEBs) and 
bronchioalveolar duct junctions (BADJs) have been revealed to replenish the 
bronchiolar epithelium (Giangreco et al., 2002; Hong et al., 2001; Rawlins et al., 
2009; Reynolds et al., 2000; Stripp et al., 1995). By exploiting the bleomycin- and 
influenza-induced alveolar injury models, club cells have been demonstrated to 
produce alveolar lineage cells (Rock et al., 2011b; Tropea et al., 2012; Vaughan et 
al., 2015; Zuo et al., 2015). At BADJ regions, bronchioalveolar stem cells (BASCs) 
expressing both Scgb1a1 and Sftpc, which are the markers for club and alveolar 
type II cells (AT2) respectively, have been suggested to be stem cells that can 
expand after naphthalene- and bleomycin-induced injury in vivo (Kim et al., 2005). 
These cells also show multi-lineage differentiation into bronchiolar and alveolar 
lineages in vitro in the 3D organoid culture system (Lee et al., 2014). Endothelial 
derived Thrombospondin-1 has been suggested to induce alveolar lineage 
differentiation of BASCs during bleomycin-induced alveolar damage repair. In 
response to cytokines such as IL-13, club cells can also generate goblet cells 
(Atherton et al., 2003; Wills-Karp et al., 1998; Zhu et al., 1999). Despite of these 
advances in identifying the multi-potent differentiation capacity of club cells, the 
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heterogeneic response of club cells to different injuries and the molecular 
mechanisms regulating bronchiolar- and alveolar-lineage differentiation remain to be 
uncovered.  
AT2 cells. The distal alveolar region is lined by surfactant-producing AT2 and gas-
exchanging AT1 cells. Lineage tracing studies have shown that AT2 cells function as 
stem and progenitor cells that self-renew and give rise to AT1 cells in the steady 
state and during regeneration after injury (Barkauskas et al., 2013; Desai et al., 
2014). A recent study performing partial pneumonectomy-induced damage has 
suggested an unexpected plasticity of the terminally differentiated AT1 cells 
expressing homeodomain only protein x (Hopx). These rare AT1 cells have the 
potential to undergo reprogramming and become AT2 cells during alveolar regrowth 
(Jain et al., 2015). Such findings and further understanding of molecular 
mechanisms underlying cell fate changes are important for respiratory disorders 
such as idiopathic pulmonary fibrosis which affect alveolar structures and function.  
2.2. Epithelial stem and progenitor cells of the adult human lung 
In the human lung, the epithelium containing basal cells extends to the terminal 
bronchioles, while this region is restricted to the trachea in mice. In contrast to 
studies using mouse models, the limited availability of normal human lung tissue has 
impeded the characterisation of adult stem and progenitor cells in the human lung. A 
number of studies have provided evidence for the existence of human lung 
progenitor cells that may share similar characteristics to their mouse counterparts. 
Recently, Teixeira et al nicely showed the clonal pattern of accumulated mutations 
that occur in the mitochondrial genome in the upper airways of human lung tissues 
suggesting the presence of clonal multi-potent progenitor cells within basal cells 
(Teixeira et al., 2013). In addition, various approaches have been applied to isolate 
and grow normal human lung epithelial cells in vitro. Dissected normal tissue from 
lung tumour resections or discarded airways from transplants or cadavers have been 
used as main sources of adult human lung cells. Nasal epithelium, bronchial 
brushing or endobronchial biopsies are also used as sources for isolating human 
respiratory basal cells (Butler et al., 2016; Hackett et al., 2011; Hegab et al., 2012; 
Mori et al., 2015; Oeztuerk-Winder et al., 2012; Randell et al., 2011; Rock et al., 
2009). We will highlight the current achievements to suggest the existence of stem 
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and progenitor cell populations in human lungs using organoid cultures in the 
following sections.  
3. Ex vivo organoid culture systems 
The scant knowledge of cellular composition in the tissue and niche environment 
surrounding stem and progenitor cells has limited our progress in identifying the 
molecular and cellular processes of organogenesis. Recent advances in our 
understanding of the stem cell microenvironment, including biological signalling 
pathways and ECM, have enabled the establishment of stem cell-derived organoid 
model systems. Using this new system, the direct observation of dynamic cellular 
changes including proliferation, differentiation, and interactions within the self-
organizing structures has become possible.  
3.1. Development of the culture platform for lung organoids 
To investigate cellular differentiation and physiological function using a simple and 
reproducible in vitro culture system, various cell and tissue culture systems have 
been established from the lung (Fig 1).   
2D culture. 2D monolayer culture systems are useful to observe and manipulate 
mammalian cells and tissues. However, 2D cultures do not completely recapitulate 
the in vivo behaviour of cells and the developmental organization of tissue. In 
particular, lung epithelial cells in 2D monolayer cultures have been shown to 
maintain their differentiated status for only a few days (Chander et al., 1983; Diglio 
and Kikkawa, 1977; Douglas et al., 1979). Even in co-culture with feeder cells such 
as irradiated mouse embryonic fibroblasts (MEFs) (Kim et al., 2005), lung epithelial 
stem cells including BASCs and AT2 cells lose expression of lung lineage markers 
such as Scgb1a1 and Sftpc in 2D monolayer culture (unpublished data). These 
model systems fail to represent 3D morphogenesis, long-term culture capacity and 
differentiation into other lineages.  
2D air-liquid interface (ALI) culture. The air-liquid interface (ALI) culture 
recapitulates a more realistic lung environment and drives airway epithelial cells to 
proliferate and differentiate in vitro (Berube et al., 2010; Vaughan et al., 2006; Wong 
et al., 2012). In this culture system, cells are seeded on the apical surface of the 
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permeable membrane of transwell inserts, followed by placing media in both of upper 
and lower chamber. After reaching confluency, the media is removed from the upper 
chamber to induce differentiation. The apical side of the cells is exposed to air while 
the basolateral side is exposed to media through the transwell membrane, thus 
mimicking the pseudostratified mucociliary microenvironment observed in vivo. 
Under these conditions, cells develop tight junctions and a differentiation state 
similar to that reached in vivo, with ciliated, basal, and secretory cells. For example, 
using ALI cultures, human bronchial epithelial cells (HBEC) have been shown to 
differentiate into mucociliary cells (Bals et al., 2004; Fulcher and Randell, 2013; 
Neuringer et al., 2005; Pageau et al., 2011; Whitcutt et al., 1988). Despite these 
advantages, lack of tissue architecture with multi-cellular differentiation resulted in 
developing 3D culture system.  
3D-submerged culture. Organ cultures with fetal lung explants demonstrated 
branching of the bronchial tract and lobules, yet no further cellular differentiation was 
observed (Alescio and Colombo Piperno, 1967; Zimmermann, 1987). Adult stem 
cells actively interact with their microenvironment and the behaviour of stem cells is 
finely regulated by extrinsic factors derived from the niche. Thus, engineered niche 
systems are absolutely required to promote the tissue-specific differentiation of 
epithelial stem cells. The basement membrane extract (known as BME or Matrigel) 
was first established from mouse tumour as a crude mixture composed of laminin, 
fibronectin, and collagen. It liquefies at 4°C, gels under physiological conditions (24-
37°C), and provides a physical framework similar to in vivo tissue (Benton et al., 
2014; Peerani and Zandstra, 2010; Vazin and Schaffer, 2010). Organoids embedded 
in 3D ECM have been widely used for the study of branching morphogenesis of 
several epithelial cell types including those from the lung (Fata et al., 2007; Liu et al., 
2004; Qiao et al., 1999; Simian et al., 2001). The cells are suspended with growth 
factor reduced Matrigel and loaded onto multi-well plates, followed by adding media 
to cover organoid droplets. Alternatively, prior to seeding, the chamber bottom was 
coated with 25-100% Matrigel that was allowed to gel. Mixture of cells with 2-5% 
Matrigel in media is layered on pre-coated chamber (Rock et al., 2011b; Rock et al., 
2009; Tata et al., 2013). Organoids are derived from single cells and grow clonally. 
However, establishing long-term expanding 3D organoids has required tissue-
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specific modifications that reflect the niche microenvironment for proper in vitro 
expansion of progenitors as well as differentiation of specific cell types. 
3D-ALI combined culture. Recent studies introduced the combination of these two 
systems, Matrigel (3D) and ALI, into the adult stem/progenitor derived-lung organoid 
culture (Barkauskas et al., 2013; Chen et al., 2012; Lee et al., 2014; McQualter et al., 
2010). The cells are mixed at a 1:1 ratio with growth factor reduced Matrigel in media 
and plated on top of transwell inserts. Media is placed in the lower chamber where 
the nutrients and signalling molecules are delivered through the semipermeable 
membrane. Importantly, 3D-ALI combined culture promotes organoid formation 
including increased colony forming efficiency with multi-lineage differentiation (Fig 
2A), possibly by creating a supportive microenvironment for expansion, polarization 
and differentiation of adult distal lung progenitor cells. However, it still remains to 
elucidate whether these cells sense a gradient of airs or nutrients to create epithelial 
polarity which may affect lineage differentiation within organoids. Furthermore, this 
system enables the addition or removal of components that constitute the 
microenvironment of lung tissues, such as stromal cells or secreted molecules which 
can be added either to the mixture of cells and Matrigel or to the lower chamber of 
plates in media. Taken together, 3D-ALI cultures make it easier to recapitulate a 
more realistic microenvironment to understand the crosstalk between adult lung stem 
cells and their niches. 
3.2. Establishment of lung organoids from adult epithelial stem cells 
Lung organoids derived from adult stem and progenitor cells have been successfully 
established from several groups and have proven to be a powerful culture system 
that enables the prolonged long-term growth and expansion of adult lung stem and 
progenitor cells whilst preserving their differentiation potential. Thus, it provides a 
useful in vitro tool to study regenerative potential of these cells that have been 
identified by in vivo studies. Here we will discuss currently available advanced 3D 
organoid culture systems for proximal and distal adult lung stem and progenitor cells 
in mouse and human (Table 1).  
Lung organoids derived from tracheal and proximal airway stem and 
progenitor cells. For lung organoids derived from mouse basal cells, primary Krt5+, 
Ngfr+Itga6+ or GSIβ4+ cells isolated from the trachea are cultured in mTEC/Plus 
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growth media in either 3D-submerged culture or 3D-ALI combined culture (the 
precise composition of the culture medium is described in Table 2) (Rock et al., 
2011b; Rock et al., 2009; Tata et al., 2013). Despite broad uses of mTEC/Plus media 
in basal cell culture, it is not defined media but basic media containing various 
growth factors including EGF which is critical for proliferation of cells. Basal cells 
develop multi-cellular spheres with ciliated and secretory cells surrounding a single, 
central lumen structure. Trp63+ basal cells are present in the outer layer of spheres 
and luminal cells including ciliated cells are found in the inner layer of spheres (Fig 
2B). Observation of variation in size of spheres (diameter, 150-500µm) and 
proportion of differentiated cells within spheres suggests the heterogeneity of 
sphere-forming cell populations in isolated basal cells. After 14 days in culture, 
spheres can be collected to be re-seeded at a 1:10 dilution in Matrigel following by 
either enzymatic digestion or mechanical dissociation for the next round culture or 
fixed in fixatives for immunostaining analysis. For lung organoids derived from 
human basal cells, freshly isolated Ngfr+Itga6+ cells cultured in 1:1 Matrigel/ALI 
media (Table 2) have been shown to generate spheres containing Krt14+Trp63+ 
basal cells and ciliated cells (Rock et al., 2009). Similarly, Ngfr+CD166+CD44+ 
epithelial cells isolated from human trachea and submucosal glands are able to form 
luminal structures comprising Krt5+Krt14+ basal cells, mucous- and serous-secretory 
epithelial cells in the same 1:1 mixture of Matrigel and mTEC/Plus medium (Hegab 
et al., 2012; You and Brody, 2013; You et al., 2002). Similar to mouse basal cell 
culture, culture media for human basal cells are not fully defined. Two basic media 
have been used for basal cell culture; a basal media for expansion and ALI media for 
differentiation. Together, these studies strongly suggest that the 3D organoid culture 
system is an efficient and powerful in vitro system to maintain the regenerative 
capacity of basal cells from both mouse and human. Despite these remarkable 
achievements, the prolonged expansion of basal cells whilst maintaining genetic 
stability and functional activity still remains challenging, in part due to a lack of the 
defined media which can be achieved by understanding molecular mechanisms 
underlying regulation of cell fate changes. A recent study reported the retardation of 
luminal cell differentiation with expansion of basal cells when TGFβ/BMP/SMAD 
signalling was inhibited (Mou et al., 2016). However, better culture conditions for 
preserving cellular function in these cells will be the next step on which to focus. In 
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addition, the variation in cellular compositions and organization between and within 
human lung tissue samples needs to be considered for evaluating cellular changes 
and functional properties of these cells in culture. 
Lung organoids derived from distal airway stem and progenitor cells. Three 
dimensional-ALI organoid cultures provide a reliable in vitro model system for the 
regeneration of distal airways and alveolar epithelium from endogenous airway stem 
and progenitor cells. Importantly, the limited ability of distal stem and progenitor cells 
to form organoids in the absence of supporting cells has led to developing a more 
advanced culture system, called organoid co-culture. Various methods have been 
developed to isolate club cells or subsets of club cells using surface markers or 
Scgb1a1-CreER knock-in allele which labels club cells. Distal 
EpCAMhiItgα6+β4+CD24low lung epithelial cells have developed distinct morphological 
spheres only when co-cultured with EpCAM-Sca-1+ lung mesenchymal cells followed 
by seeding onto the transwell insert in 1:1 Matrigel/3D basic media (Table 2) 
(McQualter et al., 2010). After 14 days in culture, individual spheres in this culture 
were reported to retain airway and/or alveolar lineage cells. Co-culture of 
CD45‒CD31‒CD34‒ (Lin‒) Sca-1low epithelial cells or lineage-labelled club cells from 
Scgb1a1-CreER;Rosa26-mT/mG mice with an immortalized fibroblast cell line (MLg, 
neonatal mouse lung fibroblasts) in 3D basic media has also revealed subsets of 
distal epithelial progenitor cells producing airway and/or alveolar lineage cells (Chen 
et al., 2012; Teisanu et al., 2011). In this culture, TGFβ inhibitor (SB431542) was 
added to allow cell growth for the initial 7-10 days. A more elegant study has been 
done with cells isolated from transgenic Sftpc-GFP mice which allow for the 
segregation of airway epithelial cells located in the different regions based on 
expression levels of GFP fluorescence (Chen et al., 2012). GFP- cells, located in the 
proximal airways, generated cystic spheres retaining airway lineage cells, whereas 
GFPhi cells, located in the terminal bronchioles and alveoli, formed alveolar-like 
spheres retaining alveolar lineage cells. GFPlow cells, located in the bronchioles, 
revealed to retain progenitor cells that give rise to airway and alveolar lineage cells. 
More recently, isolated EpCAM+Sca-1+ BASCs have been demonstrated to generate 
distinct spheres including bronchiolar, alveolar, and bronchioalveolar (mixe) spheres 
when co-cultured with mouse lung endothelial cells (LuMECs) (Fig 2C) (Lee et al., 
2014). The spheres derived from a single EpCAM+Sca-1+ BASCs retain multiple 
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lineages including club cells, ciliated cells, goblet cells, AT2 and AT1 cells. Sftpc+ 
AT2 cells are found in the outer layer of branching spheres and airway cells including 
Scgb1a1+club cells, Acetyl-tub+ciliated cells, and Muc5ac+goblet cells reside inside 
of spheres (Fig 2D)(Lee et al., 2014). Low incidence of this “bronchioalveolar” sphere 
formation from EpCAM+Sca-1+ BASCs suggests the strong need of additional 
surface markers to isolate pure BASCs which may retain multi-potency in lung 
regeneration. At 14 days in culture, dissociated organoids are sorted by EpCAM and 
re-seeded with fresh stromal cells for the next round culture. Co-culture with 
LuMECs permits the clonal long-term expansion of BASCs whilst maintaining their 
differentiation potential for more than 6 months by bi-weekly passages (Fig 2E). 
Moreover, bronchioalveolar spheres were able to form epithelial structures retaining 
Sftpc- and/or Scgb1a1-expressing cells when co-transplanted into recipient mice 
with LuMEC subcutaneously. Given the heterogeneity of airway epithelial stem and 
progenitor cells in their regenerative potential, tracing individual cell populations 
producing distinct spheres using real-time live imaging combined with a reporter 
assay could provide important clues to define the subsets of progenitor cells giving 
rise to specific lineage cells.  
Lung organoids derived from alveolar stem and progenitor cells.  For organoid 
cultures of alveolar epithelium, lineage-labelled AT2 cells from Sftpc-CreER;Rosa-
Tomato mice or GFPhi cells from Sftpc-H2B-GFP mice were placed into 3D-ALI co-
culture with Pdgfrα+ stromal cells or lung fibroblasts (MLg), respectively (Barkauskas 
et al., 2013; Lee et al., 2013). Alternatively using cell surface markers, EpCAMmed or 
EpCAM+Sca-1- cells isolated from distal lungs were also cultured with EpCAM-Sca1+ 
lung mesenchymal cells or LuMECs, respectively (Lee et al., 2014; McQualter et al., 
2010). Alveolar-like structures were formed and consisted of alveolar lineage cells, 
including Sftpc-expressing AT2 cells in the outer layer of branching spheres and AT1 
cells expressing T1α (Pdpn) and homeodomain only protein x (Hopx) within the 
spheres (Barkauskas et al., 2013). Notably, no proliferating spheres were seen when 
AT2 cells were plated in 3D-ALI culture without stromal cells, indicating the 
requirement of niche factors supplied in a direct or indirect manner for the stem cell 
activity of AT2 cells. EpCAM+HTII-280+ AT2 cells derived from human lungs formed 
alveolar spheres in 3D-ALI co-cultures with human lung fibroblasts (MRC5). 
However, no cells morphologically resembling or expressing AT1 markers were 
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detected in these spheres (Barkauskas et al., 2013). Together, these studies 
demonstrate the utility of organoid cultures in investigating the differentiation 
potential of distal lung stem cells. Furthermore, 3D-ALI organoid culture systems 
combined with co-cultures are able to answer specific questions about the function of 
the niche in the regulation of adult lung stem cells and the signalling involved in this 
process. In other hand, defining the niche factors required for distal epithelial 
organoid formation will lead to develop a stroma-free culture system which allow for 
the robust expansion of distal lung organoids and their genetic manipulation.  
4. Applications of lung organoids 
An additional advantage of adult stem cell-derived lung organoids is that they allow 
for the expansion of lung stem cell populations and the induction of differentiated 
cells from very limited amounts of starting material. These special characteristics of 
organoids provide us with an excellent model system for a wide range of applications 
both in basic and translational approaches such as drug screening, disease 
modelling and genetic screening. We will discuss current and potential applications 
of lung organoids. 
4.1. Organoids for understanding lung tissue regeneration and niche function 
The organoids derived from adult stem and progenitor cells reliably retain their in 
vivo regenerative programme in vitro thus provide detailed snapshots of tissue 
restoration after injury. For example, club cells maintain bronchiolar epithelium by 
self-renewal over the long-term, producing ciliated cells, and barely contribute to 
alveolar epithelium in the steady state (Rawlins et al., 2009). However, under certain 
conditions such as bleomycin-induced damage, club cells actively replace damaged 
alveolar epithelial cells (Rock et al., 2011a; Tropea et al., 2012). In 3D-ALI organoid 
culture of club cells or subsets of club cells including BASCs, clonal organoids 
retaining airway and/or alveolar lineage cells are generated from uninjured club cells. 
This suggests that in vitro organoid culture conditions promote the activation of the 
stem or progenitor programme, thereby providing a powerful model for studying the 
early reprogramming phases of the differentiated mature cells to an uncommitted 
state (Chen et al., 2012; Lee et al., 2014; McQualter et al., 2010). Moreover, recent 
studies took the advantage of this organoid system in screening factors that impact 
lineage specification of stem cells. IL-6, of which expression is changed in stroma 
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during injury repair, revealed to induce basal cell differentiation toward a ciliated cell 
fate versus secretory club cells (Tadokoro et al., 2014). The bronchosphere from 
human basal cells respond to IL-13 which directs goblet cell lineage with a decline in 
ciliated cells (Danahay et al., 2015). Inhibition of BMP signalling using BMP 
antagonist promoted proliferation and clonal expansion of basal cells without 
changes in lineage specification (Tadokoro et al., 2016). It remains to be validated if 
differentiation of organoids gives rise to mature functional epithelial cells which can 
be used for transplantation. 
In addition, lung organoids allow researchers to study the processes governing the 
homeostatic regulation of lung tissue and, most importantly, to gain insights into the 
interaction and crosstalk between stem cells and their niche. Whereas our capacity 
to initiate the specific alteration either of stromal cells or ECM composition in vivo is 
limited, the organoid co-culture system makes it possible to precisely manipulate the 
components of the microenvironment in order to further determine their functional 
roles in modulating lung stem cells. Lipofibroblasts expressing Pdgfrα have been 
reported to support alveolar organoid formation from adult AT2 cells (Barkauskas et 
al., 2013). Fully differentiated AT1 cells were found in these organoids, confirming 
the regulatory role of the Pdgfrα signaling pathway in alveologenesis. A dedicated 
regulatory signalling pathway (BMP4-Bmpr1a-calcineurin/NFATc1-TSP1) that 
operates between BASCs/AT2 and endothelial cells has been demonstrated to drive 
alveolar lineage specification. (Lee et al., 2014). Notably, modification of LuMECs in 
co-culture of BASCs directed lineage specification of BASCs suggesting extrinsic 
regulation of epithelial differentiation. Further study is required to determine the 
importance of vascular cells and these signalling pathways in lung diseases where 
dysregulated vascular cells are involved in the pathogenesis. In addition, a great 
deal of evidence has been emerging for a complex co-ordination between epithelial 
and immune cells during repair and regeneration processes after lung damage. Two-
photon analysis has shown migrating lymphocytes and myeloid cells into sites of 
damage after injury (Kreisel et al., 2010; Looney et al., 2011). Immediate damage is 
most likely a result of an acute inflammatory response from the myeloid-mediated 
breakdown of lung epithelial cells, however the protective role of immune response 
in tissue regeneration has also been reported (Johnson and Matthay, 2010; Levy 
and Serhan, 2014). Utilising co-culture system, cellular and molecular effectors of 
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immune cells in stem cell regulation can be determined. Together, the organoid 
culture system allows the study of the network between stem cells and their niche, 
and in turn this knowledge can be used in the rational design of organoid cultures to 
more closely mimic the in vivo environment.    
4.2. Organoids for disease modelling 
Preclinical models for human disease are essential for the basic understanding of 
disease pathology and its translational application into efficient treatment for patients. 
Patient-derived organoid cultures from biopsies and/or surgical resections present a 
novel improvement to this end (Neal and Kuo, 2016).  Disease modelling will likely 
be a primary focus of future organoid studies, encompassing developmental 
disorders, tumorigenesis, infectious disease and degenerative diseases.  
Organoids for lung cancer. Lung cancer is a heterogeneous disease comprised of 
different histological subtypes. These tumors arise from sequential aberrations 
allowing uncontrolled proliferation and the gradual loss of differentiation, which may 
contribute to heterogeneity of tumor cells (Hanahan and Weinberg, 2011). Although 
the cell(s)-of-origin for lineage-specific lung cancers remains unclear, evidence 
suggests that the tumor cell-of-origin and the oncogenic mutations acquired during 
tumorigenesis together determine the pathological subtype and thence the required 
therapy. Adult primary epithelial cell-derived organoids combined with CRISPR/Cas-
mediated genetic engineering technology may allow converting normal organoids 
into their respective malignancies in the dish by adding combinations of cancerous 
mutations as a sequential manner. The majority of lung cancer-driver mutations have 
been reported to occur early during tumorigenesis. Therefore, establishing a model 
system for functional validation of critical drivers that convert the organoids to a 
cancerous phenotype will advance the detection of early tumorigenic events which 
would be an important step towards an improved prognosis for lung cancer. In 
addition, driving tumorigenesis in diverse adult lung stem and progenitor cells, such 
as basal cells, BASCs and AT2 cells, which have been suggested as the cell-of-
origin in non-small cell lung cancer (NSCLC) (Chen et al., 2014), will provide a model 
systems not only to recapitulate human lung cancer but also to further assess 
responses to combination drug therapy based on specific subtype and genotype 
vulnerabilities.  
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Organoids for cystic fibrosis (CF). Model systems for cystic fibrosis (CF) in mice 
containing mutations in the CFTR gene fail to sufficiently recapitulate the human 
symptoms of the disease (Cohen and Prince, 2012; Ratjen and Doring, 2003). 
Therefore, patient-derived organoids from both adult tissues and induced pluripotent 
stem cells (iPSCs) represent an alternative tool for studying the biology and 
pathology of cystic fibrosis. The expansion capacity of patient-derived organoids 
provides the opportunity for high-throughput analysis, including molecular 
pathogenesis, genetic screening and the reliable ex vivo study of cell signalling 
pathways in the disease environment. A recent study demonstrating the successful 
generation of CF patient-specific airway epithelium via non-invasive approaches 
such as bronchoscopic lavage or nasal brushing is expected to advance the 
application of patient-derived organoids in disease modelling (Mou et al., 2016). 
However, the partial loss of cellular physiological function including is gradual loss of 
CFTR-mediated chloride and ENaC-mediated sodium conductance in these in vitro-
expanded epithelia will have to be resolved. Future work will be needed to better 
establish an organoid culture model that is amenable to genetic engineering, 
following assessment of physiological properties, in adult lung epithelial cells.   
4.3. Organoids for drug development and therapeutics 
Recent advances in growing adult epithelial stem cells allow patient samples to be 
maintained and grown in culture. This ability to rapidly generate organoids from 
individual patients enables the personalized testing of chemotherapies and targeted 
therapies. Recently, patient-derived organoids from human lung cancer biopsies 
have been established and have enabled the analysis of resistance mechanisms for 
targeted therapies in individual patients (Endo et al., 2013; Kimura et al., 2015). Lung 
tumor organoids derived from individual human samples were cultured in Matrigel 
with a high success rate. Importantly, it is possible to establish organoids derived 
from non-cancerous and cancer region from individual patient. In this study, the 
neuregulin 1 (Ngr1)-Her3 signalling pathway proved to be essential for the culture of 
organoids from NSCLCs. This lung patient-derived organoid model system has been 
utilized to examine the canonical sensitivity of Egfr-mutant lung cancer to the 
tyrosine kinase inhibitor (TKI) Erlotinib and to analyse the mechanism of resistance 
to Crizotinib in lung cancer patients harboring the Eml-Alk4 fusion. Interestingly, 
efficiency of tumor organoid formation varies in lung tumor subtypes; organoids from 
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adenocarcinoma have the benefit of growth compared to one from squamous 
carcinoma. Identifying niche factor requirements for tumor organoids of each 
subtypes will provide insight into predicting the drug-resistance of specific tumor 
subtypes. Finally, the ability to expand organoids retaining stem cell populations 
enables the screening of small molecules or drugs that govern lineage specification 
as discussed previously. Such screens will provide the insight into developing new 
therapies for lung diseases in which the specific lineages are disrupted.  
5. Future prospects in lung organoid systems  
Knowledge about lung stem cells during homeostasis and regeneration has 
markedly increased through recent research. Advances in understanding the role of 
the stem cell microenvironment and the crosstalk between stem cells and their niche 
has allowed researchers to develop highly reproducible organoid systems that 
closely recapitulate in vivo conditions to study tissue regeneration. Using lung 
organoids, we can investigate the function of lung stem cells residing in distinctive 
regions of lung tissue, while also monitoring their behaviour in diverse 
microenvironments. Although lung organoid culture systems are still in their infancy, 
it is becoming possible to extend their usage to biomedical applications such as in 
disease modelling and treatment. Generation of patient-derived organoids from 
biopsies provide a powerful resource for a wide range of translational and medical 
approaches. This system will be useful for studying drug toxicity and efficacy to 
finally realize the promise of personalized medicine. However, there are still a 
number of concerns that need to be addressed: 1) The physiological functions of 
differentiated cells need to be preserved over time in organoid culture. 2) Optimised 
culture conditions for the reproducible direction of lineage specification with high 
efficiency are essential to enable organoid cultures to have clinical impact. 3) The 
limited presence of niche components in the organoid system restricts the study of 
their role in lung disease modelling, such as during the inflammatory response to 
injury or drug administration. 4) Epigenetic modulation, which can result in genetic 
instability, needs to be evaluated in long-term cultures of lung organoids. 5) Variation 
in patient-to-patient needs to be considered for establishing patient-derived 
organoids which can be used for the therapeutic purpose. 6) A high-throughput 
platform for screening molecules and drugs in 3D organoids, already shown to be 
18		
feasible (Danahay et al., 2015), and the analysis of downstream target gene 
expression should be established with better read-out methods. Such trials could 
represent a new generation of a drug screening for pharmacogenomics profiling that 
may lead early-phase clinical trials of novel drugs and rational therapeutic strategies.    
Addressing the remaining issues described above in lung organoids would provide 
important advances towards the bioengineering of whole lung tissue and could 
significantly extend their utility in various arenas. The novel and rapid advances in 
lung organoid technology offer a promising perspective for studying lung 
development and for future clinical applications.     
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Figure Legends 
Figure 1. Culture platform for lung organoids. (Top) Primary airway epithelial cells 
are placed on standard tissue culture plates prior to passage and introduction to 
differentiation condition in air-liquid interface (ALI) culture. Expansion phase is 
followed by ALI culture, which drives differentiation and exhibits characteristic 
properties of airway cells, including mucus secretion, ciliary motility and formation of 
tight junction. (Middle) Primary airway epithelial cells are mixed with a gel of 
extracellular matrix (ECM) protein (Matrigel) and placed on standard tissue culture 
plates. ALI media to induce lineage differentiation are fed in every other day. Airway 
stem and progenitor cells clonally grow to form 3D spheres. (Bottom) A mixture of 
primary airway epithelial cells with Matrigel is placed on transwell insert and is 
exposed to medium in ALI, which allows nutrient diffusion without submersion. 
Further advanced co-culture system has been employed by adding stromal cells in 
this mixture.  
Figure 2. Lung organoids grown in vitro. (A) Representative images of organoids 
derived from 5,000 EpCAM+Sca1+BASCs in 3D-submerged co-culture (left) or 3D-
ALI co-culture (right) with mouse lung endothelial cells (LuMECs) at 14 days in 
culture. Note better organoid formation of BASCs in 3D-ALI culture compared to one 
in 3D-submerged culture. Scale bar, 500um. (B) Representative 
immunofluorescence (IF) for lung cell markers in a basal sphere derived from Ngfr+ 
mouse basal cells; Ecadherin (red), Acetylated tubulin (green), and DAPI (blue) (left); 
Trp63 (red) and DAPI (blue) (right). Scale bar, 50um. (C) Representative images of 
GFP fluorescent organoids from 3D co-culture of EpCAM+Sca1+ BASCs isolated 
from β-actin-GFP mice with LuMECs for 14 days in 3D-ALI culture. Starting with 
nearly spherical geometry, the organoids develop lumen-like structures (top), 
alveolar-like structures (middle), and mixed phenotype with distinct budding 
structures (bottom). Scale bar, 100um. (D) Representative IF for lung cell markers in 
a bronchioalveolar sphere derived from a single BASC; CCSP (red), SPC (green), 
and DAPI (blue). Scale bar, 50um. (E) The BASC organoids have been in 
continuous culture with bi-weekly passaging for 6 months and grow and differentiate 
normally. Scale bar, 500um.
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